Janus-like effects of type I interferon in autoimmune diseases.
about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesRole of microglia in CNS autoimmunityChronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasisGene expression profiling offers insights into the role of innate immune signaling in SScMechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease.Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple SclerosisActivation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß.GWAS implicates a role for quantitative immune traits and threshold effects in risk for human autoimmune disordersThe genetics of innate immunity sensors and human disease.Th17 cells in neuromyelitis optica spectrum disorder: a review.p204-Mediated innate antiviral responses in mouse adipose cells and their effects on cell functions.Interferon and interferon-inducible gene activation in patients with type 1 diabetes.Up-regulation of Kv1.3 channels by janus kinase 2.Nostalgia: the similarities between immunological and neurological memory.Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray
P2860
Q21131160-47912FE1-F37D-495C-8B1B-43C57E8E55ABQ27003940-890ED768-F61F-49ED-A4A7-E8023CC49BA9Q27330100-2E665879-BF51-4451-BA53-D174CACC6A37Q28083733-52D0BD8E-F63F-44DE-BD75-67C4939E8595Q34089188-00005A08-C15B-4D95-A5D8-A45311948DFDQ34995163-AFA7F360-A69B-46A0-B6A2-66A8CA848998Q35902459-9A4F01FD-BD2B-40E2-A709-8035CF7278E7Q36253827-2E9438E0-AB20-4B91-838B-F2851BD65372Q36593533-BA92A98F-1E47-4338-84EB-E6196367F87DQ38097500-CDF3CC44-E5FE-4062-9F38-19EE11F4B0F8Q38765404-C51F3ACF-D77E-4F78-AF41-92A46EC09764Q42184441-2E118920-7E6B-41BD-8DDF-1D71080E664DQ42209992-1D8D46B5-2CE4-4FB7-A6F8-FA5DD89026C1Q48586068-8E5E0740-6537-43F0-AB0C-77198278F6E8Q50799946-81D5975D-25B3-4882-836C-8068091E3C1AQ58412739-619B9DC8-47C2-4878-832C-D9A3972202DC
P2860
Janus-like effects of type I interferon in autoimmune diseases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Janus-like effects of type I interferon in autoimmune diseases.
@ast
Janus-like effects of type I interferon in autoimmune diseases.
@en
type
label
Janus-like effects of type I interferon in autoimmune diseases.
@ast
Janus-like effects of type I interferon in autoimmune diseases.
@en
prefLabel
Janus-like effects of type I interferon in autoimmune diseases.
@ast
Janus-like effects of type I interferon in autoimmune diseases.
@en
P2860
P1476
Janus-like effects of type I interferon in autoimmune diseases.
@en
P2093
Chander Raman
Robert C Axtell
P2860
P356
10.1111/J.1600-065X.2012.01131.X
P577
2012-07-01T00:00:00Z